Form 8-K - Current report:
SEC Accession No. 0001564590-20-051375
Filing Date
2020-11-05
Accepted
2020-11-05 16:31:56
Documents
3
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20201105.htm 8-K 31156
2 EX-99.1 arav-ex991_14.htm EX-99.1 173082
3 GRAPHIC gijtw5fq3h1b000001.jpg GRAPHIC 2002
  Complete submission text file 0001564590-20-051375.txt   208370
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 201290984
SIC: 2834 Pharmaceutical Preparations